Yahoo Web Search

Search results

1. • Researchers explore present and future treatment options for hepatocellular carcinoma using...

     Medical Xpress· 6 days ago

     Hepatocellular carcinoma (HCC), a prevalent form of cancer, profoundly influences the progression and prognosis of the disease through immune response mechanisms ...

2. • KDM5B promotes SMAD4 loss-driven drug resistance through activating DLG1/YAP to induce lipid...

     Nature· 4 days ago

     Inactivated suppressor of mothers against decapentaplegic homolog (SMAD) 4 significantly affects cancer development in pancreatic ductal adenocarcinoma ...

3. • Can This Well-Loved Herb Help Fight Malignancies?

     Mercola· 5 days ago

     Studies2,3,4 also support the notion that this humble herb has anticancer effects, which should be good enough reason for you to include more of it in your diet. A study published ...

4. • Aadi Bioscience Presents New Nonclinical Data Demonstrating Preferential Tumor Uptake of...

     WJTV Jackson· 4 days ago

     Aadi Bioscience, Inc. (NASDAQ: AADI), a commercial-stage precision oncology company focused on developing and commercializing therapies for cancers with ...

5. • AbelZeta Announces Publication of Abstract for ASCO 2024 Annual Meeting

     FOX 23 News Albany· 4 days ago

     AbelZeta Pharma, Inc. ("AbelZeta" or the "Company"), a global clinical-stage biopharmaceutical company focused on the discovery and development of innovative and proprietary ...

6. • Biomica Presents Positive Clinical Data Update from Ongoing Phase 1 Trial of Microbiome-Based...

     WJTV Jackson· 5 days ago

     Data will be showcased at the 2024 American Society of Clinical Oncology (ASCO) annual meeting. REHOVOT, Israel, May 23, 2024 /PRNewswire/ -- Biomica Ltd., a clinical-stage

7. • Phio Pharmaceuticals Announces Presentation at the Annual Meeting of the American Society of...

     Digital Journal· 4 days ago

     ...believe that this immuno-oncology therapy may offer patients meaningful clinical benefit, while minimizing surgical...Immunotherapy for Cutaneous Carcinoma Poster Number: TPS9620...Topic: Melanoma/Skin Cancer Presenting Author: Mary...Time: June 1, 2024: 1:30-4:30 PM CDT About Phio...: PHIO) is a...

8. • Multiphase comparative study for WHO/ISUP nuclear grading diagnostic model based on enhanced CT...

     Nature· 1 day ago

     To compare and analyze the diagnostic value of different enhancement stages in distinguishing low and high nuclear grade clear cell renal cell carcinoma (ccRCC) based on enhanced ...

9. • 

     Blood-Based Test for CRC Screening Hits Sensitivity, Specificity Endpoints

     MedPage Today· 5 days ago

     A blood-based test for the early detection of colorectal cancer (CRC) met its prespecified...

10. • Mabwell Announces 9MW2821 Clinical Data and Latest Progress to be presented at 2024 ASCO Annual...

      WKBN 27 Youngstown· 4 days ago

      Of the 37 patients evaluable for efficacy assessment, the objective response rate (ORR) and disease control rate (DCR) were 62.2% and 91.9%, respectively...